Abstract: A method for manufacturing an LED lighting device includes forming a separation film on a substrate, patterning the separation film, forming LEDs on the separation film, bonding a stretch film to top surfaces of the LEDs and spacing between the LEDs, separating the separation film from the substrate, stretching the stretch film, exposing the top surfaces of the LEDs, and forming electrodes on the top surfaces of the LEDs, and a bottom surface of the separation film or bottom surfaces of the LEDs.

Abstract: Provided is a conductive pattern having at least one unit conductive pattern forming one touch pixel according to an aspect of the present invention. The at least one unit conductive pattern includes a plurality of nanostructures each having opposite ends. A ratio of nanostructures, both opposite ends of which are in contact with edges of the at least one unit conductive pattern to all nanostructures included in the at least one unit conductive pattern is 70% or more.

Abstract: A transparent electrode structure according to an embodiment of the present invention includes a transparent substrate, a transparent electrode layer disposed on the transparent substrate and including a multi-layered structure of a transparent oxide electrode layer and a metal layer, and a barrier structure disposed between the transparent substrate and the transparent electrode layer and including at least one barrier material of an aluminum oxide-zinc oxide composite (AlZO) material, silazane, siloxane or a silicon-containing inorganic material. Electrical, optical and chemical stability may be improved by a combination of the transparent electrode layer and the barrier structure.

Abstract: A conductive sheet according to an aspect of the present invention includes a first nanostructure and a second nanostructure disposed to intersect each other. A thickness of an intersect region of the first nanostructure and the second nanostructure is 0.6 to 0.9 times the sum of thicknesses of non-intersection regions of the first nanostructure and the second nanostructure.

Abstract: Provided is a conductive pattern having at least one unit conductive pattern forming one touch pixel according to an aspect of the present invention. The at least one unit conductive pattern includes a plurality of nanostructures each having opposite ends. A ratio of nanostructures, both opposite ends of which are in contact with edges of the at least one unit conductive pattern to all nanostructures included in the at least one unit conductive pattern is 70% or more.

Abstract: Provided is a conductive pattern having at least one unit conductive pattern forming one touch pixel according to an aspect of the present invention. The at least one unit conductive pattern includes a plurality of nanostructures each having opposite ends. A ratio of nanostructures, both opposite ends of which are in contact with edges of the at least one unit conductive pattern to all nanostructures included in the at least one unit conductive pattern is 70% or more.

Abstract: A conductive sheet according to an aspect of the present invention includes a first nanostructure and a second nanostructure disposed to intersect each other. A thickness of an intersect region of the first nanostructure and the second nanostructure is 0.6 to 0.9 times the sum of thicknesses of non-intersection regions of the first nanostructure and the second nanostructure.

Abstract: A transparent electrode includes a first metal oxide layer, a metal layer and a second metal oxide layer. The first metal oxide layer, the metal layer and the second metal oxide layer are sequentially stacked to form a mesh pattern. A reflectivity at a wavelength of 550 nm of the mesh pattern is in a range from 5% to 20%.

Abstract: A conductive sheet according to an aspect of the present invention includes a first nanostructure and a second nanostructure disposed to intersect each other. A thickness of an intersect region of the first nanostructure and the second nanostructure is 0.6 to 0.9 times the sum of thicknesses of non-intersection regions of the first nanostructure and the second nanostructure.

Abstract: The present invention relates to a force touch sensor and a manufacturing method thereof. The force touch sensor according to the present invention includes a lower electrode layer bonded to a display, an upper electrode layer bonded to a polarizing plate, and a transparent dielectric layer bonded to the lower electrode layer and the upper electrode layer. According to the present invention, thin film characteristics and flexible characteristics may be improved, manufacturing costs and manufacturing time may be reduced, and manufacturing processes may be simplified and product yield may be improved by simplifying functional layers constituting the force touch sensor.

Abstract: A transparent electrode includes a first metal oxide layer, a metal layer and a second metal oxide layer. The first metal oxide layer, the metal layer and the second metal oxide layer are sequentially stacked to form a mesh pattern. A reflectivity at a wavelength of 550 nm of the mesh pattern is in a range from 5% to 20%.

Abstract: Provided is a conductive pattern having at least one unit conductive pattern forming one touch pixel according to an aspect of the present invention. The at least one unit conductive pattern includes a plurality of nanostructures each having opposite ends. A ratio of nanostructures, both opposite ends of which are in contact with edges of the at least one unit conductive pattern to all nanostructures included in the at least one unit conductive pattern is 70% or more.

Abstract: A conductive sheet according to an aspect of the present invention includes a first nanostructure and a second nanostructure disposed to intersect each other. A thickness of an intersect region of the first nanostructure and the second nanostructure is 0.6 to 0.9 times the sum of thicknesses of non-intersection regions of the first nanostructure and the second nanostructure.

Abstract: The present invention relates to a pharmaceutical composition for the treatment of wounds containing blood plasma or serum and a method for treating wounds effectively by applying said composition to the wound site to normalize the tissue-environment around the site.

Abstract: The present invention relates to nucleic acid probes which are derived from rRNA genes of non-virus organisms and are useful for the detection of said non-virus infectious organisms in a biological sample. In addition, the present invention relates to compositions and chips useful for the diagnosis of one or more types of infectious diseases comprising said nucleic acid probes.

Abstract: The present invention relates to methods and compositions for inhibiting scar formation on wound region. In certain embodiments, the methods include administering an alkalinization agent in combination with hyaluronic acid to a wound site to reduce the formation of scars at the wound site. Suitable alkalization agents include sodium bicarbonate, sodium hydroxide and potassium hydroxide.

Abstract: The present invention relates to a pharmaceutical composition for inhibiting scar formation on wound region which consists of hyaluronic acid and alkalization agent such as sodium bicarbonate, NaOH, and KOH.

Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.

Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.

Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.